Azithromycin for treatment of bronchiolitis obliterans syndrome in adult lung transplant recipients

Safavi, Shahideh; Prayle, Andrew P.; Hall, Ian P.; Parmar, Jasvir

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: This review aims to look at the benefits and harms of azithromycin for the treatment of BOS in adult lung transplant recipients.

Citation

Safavi, S., Prayle, A. P., Hall, I. P., & Parmar, J. (in press). Azithromycin for treatment of bronchiolitis obliterans syndrome in adult lung transplant recipients. Cochrane Database of Systematic Reviews, 2017(9), Article CD012782. https://doi.org/10.1002/14651858.CD012782

• Journal Article Type: Article
• Acceptance Date: Jul 12, 2017
• Online Publication Date: Sep 4, 2017
• Deposit Date: Feb 12, 2018
• Publicly Available Date: Sep 5, 2018
• Journal: Cochrane Database of Systematic Reviews
• Electronic ISSN: 1469-493X
• Publisher: Cochrane Collaboration
• Peer Reviewed: Peer Reviewed
• Volume: 2017
• Issue: 9
• Article Number: CD012782
• DOI: https://doi.org/10.1002/14651858.CD012782
• Public URL: https://nottingham-repository.worktribe.com/output/881107
• Publisher URL: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD012782/abstract
• Contract Date: Feb 12, 2018